Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Inventory (2024 - 2025)

Autolus Therapeutics' Inventory history spans 2 years, with the latest figure at $33.2 million for Q4 2025.

  • For Q4 2025, Inventory rose 702.54% year-over-year to $33.2 million; the TTM value through Dec 2025 reached $33.2 million, up 702.54%, while the annual FY2025 figure was $33.2 million, 702.54% up from the prior year.
  • Inventory reached $33.2 million in Q4 2025 per AUTL's latest filing, up from $27.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $33.2 million in Q4 2025 to a low of $4.1 million in Q4 2024.